• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

澳大利亚乳腺癌的治疗成本及其对乳腺癌筛查的影响。

The costs of treating breast cancer in Australia and the implications for breast cancer screening.

作者信息

Butler J R, Furnival C M, Hart R F

机构信息

National Centre for Epidemiology and Population Health, Australian National University, Canberra.

出版信息

Aust N Z J Surg. 1995 Jul;65(7):485-91. doi: 10.1111/j.1445-2197.1995.tb01791.x.

DOI:10.1111/j.1445-2197.1995.tb01791.x
PMID:7611968
Abstract

The aim of the study was to determine if there is a relationship between the stage of breast cancer at the time of detection and the costs of treatment and to assess whether any such relationship would have an influence on the cost of a mammographic screening programme. A retrospective analysis of the stage at presentation for primary breast cancer and the treatment costs over the duration of treatment was made. Multiple regression analysis was employed, with treatment cost as the dependent variable and categorical variables to represent stage at detection. A total of 301 women whose treatment for breast cancer commenced at the Royal Brisbane Hospital participated in the study. A statistically significant relationship was found between the stage of disease at the time of detection and subsequent treatment costs; more advanced stages of disease incurred higher treatment costs. This relationship was robust even after taking into account the age of patients, their discharge status, and differences between patients in the duration of treatment. When the effect of earlier detection on treatment cost was assessed in relation to a breast screening programme, cost savings were estimated to be in the range of 8-36% of total screening costs. There are treatment cost savings to be gained from breast cancer screening as a result of the detection of earlier stages of disease. These treatment cost savings should be offset against the cost of a mammographic screening programme.

摘要

该研究的目的是确定乳腺癌在被发现时的分期与治疗费用之间是否存在关联,并评估这种关联是否会对乳房X光筛查项目的成本产生影响。对原发性乳腺癌确诊时的分期以及整个治疗期间的治疗费用进行了回顾性分析。采用多元回归分析,将治疗费用作为因变量,用分类变量表示发现时的分期。共有301名在皇家布里斯班医院开始接受乳腺癌治疗的女性参与了该研究。研究发现,发现疾病时的分期与后续治疗费用之间存在统计学上的显著关联;疾病分期越晚,治疗费用越高。即使考虑到患者的年龄、出院状态以及患者之间治疗时长的差异,这种关联依然稳固。当评估早期发现对乳房筛查项目治疗费用的影响时,估计成本节约幅度在总筛查成本的8%至36%之间。通过发现疾病的早期阶段,乳腺癌筛查能够节省治疗费用。这些治疗费用的节省应与乳房X光筛查项目的成本相抵消。

相似文献

1
The costs of treating breast cancer in Australia and the implications for breast cancer screening.澳大利亚乳腺癌的治疗成本及其对乳腺癌筛查的影响。
Aust N Z J Surg. 1995 Jul;65(7):485-91. doi: 10.1111/j.1445-2197.1995.tb01791.x.
2
Will early detection of breast cancer reduce the costs of treatment?早期发现乳腺癌会降低治疗成本吗?
Aust J Public Health. 1994 Dec;18(4):388-93. doi: 10.1111/j.1753-6405.1994.tb00269.x.
3
A cost utility analysis of mammography screening in Australia.
Soc Sci Med. 1992 May;34(9):993-1004. doi: 10.1016/0277-9536(92)90130-i.
4
Costs of breast cancer and the cost-effectiveness of breast cancer screening.乳腺癌的成本及乳腺癌筛查的成本效益
Int J Technol Assess Health Care. 1991;7(4):604-15. doi: 10.1017/s0266462300007169.
5
The costs of treating breast cancer in the United Kingdom: implications for screening.英国乳腺癌的治疗成本:对筛查的影响
Int J Technol Assess Health Care. 1998 Spring;14(2):277-89. doi: 10.1017/s0266462300012253.
6
Mammographic screening: measurement of the cost in a population based programme in Victoria, Australia.乳腺钼靶筛查:澳大利亚维多利亚州一项基于人群的项目中的成本测算
J Epidemiol Community Health. 1994 Aug;48(4):391-9. doi: 10.1136/jech.48.4.391.
7
Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.北欧国家癌症筛查对截至2017年的死亡、成本和生活质量的影响。
Acta Oncol. 1997;36 Suppl 9:1-60.
8
9
Cost-effectiveness of breast cancer screening in women on dialysis.透析女性乳腺癌筛查的成本效益
Am J Kidney Dis. 2008 Nov;52(5):916-29. doi: 10.1053/j.ajkd.2008.06.015. Epub 2008 Sep 11.
10
The costs of mammography screening in New Zealand: evidence from the pilot programmes.新西兰乳腺钼靶筛查的成本:来自试点项目的证据。
N Z Med J. 1994 Dec 14;107(991):501-3.

引用本文的文献

1
Efficacy and economics of hormonal therapies for advanced breast cancer.晚期乳腺癌激素疗法的疗效与经济学分析
Drugs Aging. 2002;19(6):453-63. doi: 10.2165/00002512-200219060-00004.
2
Breast cancer racial differences before age 40--implications for screening.40岁之前乳腺癌的种族差异——对筛查的启示
J Natl Med Assoc. 2002 Mar;94(3):149-56.
3
Cost effectiveness of letrozole in the treatment of advanced breast cancer in postmenopausal women in the UK.来曲唑治疗英国绝经后妇女晚期乳腺癌的成本效益
Pharmacoeconomics. 1999 Oct;16(4):379-97. doi: 10.2165/00019053-199916040-00006.